Previous Article |
Table of Contents
| Next Article
BIOLOGICAL SCIENCES / MEDICAL SCIENCES
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth











,

*Institute for Cancer Genetics and
Joint Centers for Systems Biology, Columbia University, New York, NY 10032;
Whitehead Institute, Cambridge, MA 02142; Departments of
Pediatric Oncology and ¶Biostatistics, DanaFarber Cancer Institute, Boston, MA 02115; ||Terry Fox Laboratory, BC Cancer Research Centre, Vancouver, BC, Canada V5Z 1L3; **Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115; and 
Genome Rearrangements and Cancer Group, Institut National de la Santé et de la Recherche Médicale U728, Saint-Louis Hospital, 75010 Paris, France
Edited by Richard A. Flavell, Yale University School of Medicine, New Haven, CT, and approved October 3, 2006 (received for review July 19, 2006)
The NOTCH1 signaling pathway directly links extracellular signals with transcriptional responses in the cell nucleus and plays a critical role during T cell development and in the pathogenesis over 50% of human T cell lymphoblastic leukemia (T-ALL) cases. However, little is known about the transcriptional programs activated by NOTCH1. Using an integrative systems biology approach we show that NOTCH1 controls a feed-forward-loop transcriptional network that promotes cell growth. Inhibition of NOTCH1 signaling in T-ALL cells led to a reduction in cell size and elicited a gene expression signature dominated by down-regulated biosynthetic pathway genes. By integrating gene expression array and ChIP-on-chip data, we show that NOTCH1 directly activates multiple biosynthetic routes and induces c-MYC gene expression. Reverse engineering of regulatory networks from expression profiles showed that NOTCH1 and c-MYC govern two directly interconnected transcriptional programs containing common target genes that together regulate the growth of primary T-ALL cells. These results identify c-MYC as an essential mediator of NOTCH1 signaling and integrate NOTCH1 activation with oncogenic signaling pathways upstream of c-MYC.
T cell lymphoblastic leukemia
The authors declare no conflict of interest.
This article is a PNAS direct submission.

To whom correspondence should be addressed. E-mail: af2196{at}columbia.edu
© 2006 by The National Academy of Sciences of the USA
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
P. Van Vlierberghe, M. van Grotel, J. Tchinda, C. Lee, H. B. Beverloo, P. J. van der Spek, A. Stubbs, J. Cools, K. Nagata, M. Fornerod, et al. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia Blood, May 1, 2008; 111(9): 4668 - 4680. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. De Keersmaecker, I. Lahortiga, N. Mentens, C. Folens, L. Van Neste, S. Bekaert, P. Vandenberghe, M. D. Odero, P. Marynen, and J. Cools In vitro validation of {gamma}-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia Haematologica, April 1, 2008; 93(4): 533 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O'Neil, J. Tchinda, A. Gutierrez, L. Moreau, R. S. Maser, K.-K. Wong, W. Li, K. McKenna, X. S. Liu, B. Feng, et al. Alu elements mediate MYB gene tandem duplication in human T-ALL J. Exp. Med., December 24, 2007; 204(13): 3059 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. MARGOLIN and A. CALIFANO Theory and Limitations of Genetic Network Inference from Microarray Data Ann. N.Y. Acad. Sci., December 1, 2007; 1115(1): 51 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Spaulding, E. J. Reschly, D. E. Zagort, Y. Yashiro-Ohtani, L. J. Beverly, A. Capobianco, W. S. Pear, and B. L. Kee Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas Blood, October 1, 2007; 110(7): 2650 - 2658. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Laky and B.J. Fowlkes Presenilins regulate {alpha}{beta} T cell development by modulating TCR signaling J. Exp. Med., September 3, 2007; 204(9): 2115 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-R. Liao, R.-H. Hsieh, K.-W. Hsu, M.-Z. Wu, M.-J. Tseng, R.-T. Mai, Y.-H. Wu Lee, and T.-S. Yeh The CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1 Carcinogenesis, September 1, 2007; 28(9): 1867 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Thompson, S. Buonamici, M. L. Sulis, T. Palomero, T. Vilimas, G. Basso, A. Ferrando, and I. Aifantis The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia J. Exp. Med., August 6, 2007; 204(8): 1825 - 1835. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O'Neil, J. Grim, P. Strack, S. Rao, D. Tibbitts, C. Winter, J. Hardwick, M. Welcker, J. P. Meijerink, R. Pieters, et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to {gamma}-secretase inhibitors J. Exp. Med., August 6, 2007; 204(8): 1813 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Chan, A. P. Weng, R. Tibshirani, J. C. Aster, and P. J. Utz Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia Blood, July 1, 2007; 110(1): 278 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Guo, M. Dose, D. Kovalovsky, R. Chang, J. O'Neil, A. T. Look, H. von Boehmer, K. Khazaie, and F. Gounari {beta}-Catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation Blood, June 15, 2007; 109(12): 5463 - 5472. [Abstract] [Full Text] [PDF] |
||||